Get the app
US › Healthcare

Pliant Therapeutics Inc (PLRX)

US · Healthcare · Biotechnology

$0.90-7.46%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-22.4M
EPS
$-0.36
EPS estimate
$-0.33

EPS came in at -0.36 against a street estimate of -0.33 — a miss of 9.1%.

Key statistics

Market cap
$59.9M
Forward P/E
0.0
P/B
0.47
Book value
$2.37
EPS (TTM)
$-1.47
52-week high
$1.95
52-week low
$0.88
50-day MA
$1.10
200-day MA
$1.19
Beta
1.28

Analyst view

Analysts rate Pliant Therapeutics Inc a hold (0 buy, 3 hold, 1 sell out of 4) with an average price target of $2.00.

Shareholding

Insiders
2.23%
Institutions
78.27%

Largest institutional holders

FundStake
TANG CAPITAL MANAGEMENT LLC9.92%
ADAR1 Capital Management LLC8.90%
Vanguard Capital Management, LLC3.94%
Acadian Asset Management LLC3.90%
Two Sigma Investments LLC3.65%
Citadel Advisors Llc3.46%
Renaissance Technologies Corp3.31%
Monaco Asset Management3.13%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pliant Therapeutics Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.